CD19-directed Antibody Interactions [MoA] - N0000191422

Pharmacologic Code	N0000191422
Pharmacologic Name	CD19-directed Antibody Interactions
Pharmacologic Uses	bispecific CD19-directed CD3 T-cell engager CD19-directed cytolytic antibody
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD19-directed Antibody Interactions [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	75987-150	Uplizna	Non-Proprietary Name: Inebilizumab	Injection	Intravenous	Horizon Therapeutics Usa, Inc.	ACTIVE